VOLUME 12, ISSUE 22 / NOVEMBER 2020
Regulatory
NOVEMBER 2020
The method history report: an adaptable tool for communicating immunogenicity assay development and validation
- Kristin Hollister
, - Huy T Nguyen,
- Jessie L Bishop,
- Jeff W Cramer,
- Nicoletta Bivi ,
- Margaret A Gardner,
- Robert J Konrad &
- Michael E Hodsdon
- Pages:1597–1605
- Published Online:6 November 2020
Bioanalytical Challenge
NOVEMBER 2020
LC–MS/MS quantification of asymmetric dimethyl arginine and symmetric dimethyl arginine in plasma using surrogate matrix and derivatization with fluorescamine
- Venkatraman Junnotula,
- Barry R Jones,
- Shelby Gorman,
- Miaoqing Shen &
- Daniel Mulvana
- Pages:1607–1619
- Published Online:5 November 2020
Research Article
NOVEMBER 2020
LC–MS/MS assays to quantify sulfatides and lysosulfatide in cerebrospinal fluid of metachromatic leukodystrophy patients
- Karen (Hongmei) Cao,
- Guodong Zhang,
- Leslie Jacobsen &
- Jiang Wu
- Pages:1621–1633
- Published Online:5 November 2020
Research Article
OCTOBER 2020
Application of LC–MS/MS method for determination of dihydroartemisin in human plasma in a pharmacokinetic study
- Huanhuan Wang ,
- Xueting Yao,
- Teng Wang ,
- Shuai Yan,
- Ji Jiang,
- Fengchun Zhang,
- Junfeng Liu,
- Duo Gao,
- Zhanguo Ma,
- Qian Zhao ,
- Dongyang Liu &
- Pei Hu
- Pages:1635–1646
- Published Online:29 October 2020
Review
NOVEMBER 2020
Pharmacokinetic drug–drug interactions: an insight into recent US FDA-approved drugs for prostate cancer
- Siva Nageswara Rao Gajula,
- Gangireddy Navitha Reddy,
- Dannarm Srinivas Reddy &
- Rajesh Sonti
- Pages:1647–1664
- Published Online:6 November 2020